Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hahn, Joo-Yong | - |
dc.contributor.author | Bin Song, Young | - |
dc.contributor.author | Oh, Ju-Hyeon | - |
dc.contributor.author | Chun, Woo Jung | - |
dc.contributor.author | Park, Yong Hawn | - |
dc.contributor.author | Jang, Woo Jin | - |
dc.contributor.author | Im, Eul-Soon | - |
dc.contributor.author | Jeong, Jin-Ok | - |
dc.contributor.author | Cho, Byung Ryul | - |
dc.contributor.author | Oh, Seok Kyu | - |
dc.contributor.author | Yun, Kyeong Ho | - |
dc.contributor.author | Cho, Deok-Kyu | - |
dc.contributor.author | Lee, Jong-Young | - |
dc.contributor.author | Koh, Young-Youp | - |
dc.contributor.author | Bae, Jang-Whan | - |
dc.contributor.author | Choi, JaeWoong | - |
dc.contributor.author | Lee, Wang Soo | - |
dc.contributor.author | Yoon, Hyuck Jun | - |
dc.contributor.author | Lee, Seung Uk | - |
dc.contributor.author | Cho, Jang Hyun | - |
dc.contributor.author | Choi, Woong Gil | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Lee, Joo Myung | - |
dc.contributor.author | Park, Taek Kyu | - |
dc.contributor.author | Yang, Jeong Hoon | - |
dc.contributor.author | Choi, Jin-Ho | - |
dc.contributor.author | Choi, Seung-Hyuck | - |
dc.contributor.author | Lee, Sang Hoon | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Gwon, Hyeon-Cheol | - |
dc.contributor.author | Hahn, Joo-Yong | - |
dc.contributor.author | Bin Song, Young | - |
dc.contributor.author | Park, Taek Kyu | - |
dc.contributor.author | Lee, Joo Myung | - |
dc.contributor.author | Yang, Jeong Hoon | - |
dc.contributor.author | Choi, Jin-Ho | - |
dc.contributor.author | Lee, Sang Hoon | - |
dc.contributor.author | Kim, Dong-Bin | - |
dc.contributor.author | Cho, Byung Ryul | - |
dc.contributor.author | Choi, Woong Gil | - |
dc.contributor.author | Yoon, Hyuck Jun | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Cho, Deok-Kyu | - |
dc.contributor.author | Lee, Seung Uk | - |
dc.contributor.author | Cho, Sang Cheol | - |
dc.contributor.author | Hwang, Sun-Ho | - |
dc.contributor.author | Jeon, Dong Woon | - |
dc.contributor.author | Choi, Jae Woong | - |
dc.contributor.author | Ryu, Jae Kean | - |
dc.contributor.author | Im, Eul-Soon | - |
dc.contributor.author | Kim, Moo-Hyun | - |
dc.contributor.author | Chae, In-Ho | - |
dc.contributor.author | Oh, Ju-Hyeon | - |
dc.contributor.author | Chun, Woo Jung | - |
dc.contributor.author | Park, Yong Hawn | - |
dc.contributor.author | Jang, Woo Jin | - |
dc.contributor.author | Kim, Sang-Hyun | - |
dc.contributor.author | Kim, Hack-Lyoung | - |
dc.contributor.author | Cho, Jang Hyun | - |
dc.contributor.author | Jin, Dong Kyu | - |
dc.contributor.author | Suh, Il Woo | - |
dc.contributor.author | Park, Jong Seon | - |
dc.contributor.author | Shin, Eun-Seok | - |
dc.contributor.author | Kim, Shin-Jae | - |
dc.contributor.author | Cheong, Sang-Sig | - |
dc.contributor.author | Oh, Seok Kyu | - |
dc.contributor.author | Ho, Kyeong | - |
dc.contributor.author | Lee, Sung Yun | - |
dc.contributor.author | Lee, Jong-Young | - |
dc.contributor.author | Chae, Jei Keon | - |
dc.contributor.author | Koh, Young Youp | - |
dc.contributor.author | Lee, Wang Soo | - |
dc.contributor.author | Yang, Yong Mo | - |
dc.contributor.author | Jeong, Jin-Ok | - |
dc.contributor.author | Bae, Jang-Whan | - |
dc.contributor.author | Choi, Joon-Hyouk | - |
dc.contributor.author | Yu, Cheol Woong | - |
dc.contributor.author | Kim, Seon Woo | - |
dc.contributor.author | Choi, So Yeon | - |
dc.contributor.author | Kim, Hyun-Joong | - |
dc.contributor.author | Kim, Byeong-Keuk | - |
dc.contributor.author | Park, Seung Jung | - |
dc.date.accessioned | 2021-09-01T13:37:41Z | - |
dc.date.available | 2021-09-01T13:37:41Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-06-25 | - |
dc.identifier.issn | 0098-7484 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/64732 | - |
dc.description.abstract | IMPORTANCE Data on P2Y12 inhibitor monotherapy after short-duration dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention are limited. OBJECTIVE To determine whether P2Y12 inhibitor monotherapy after 3 months of DAPT is noninferior to 12 months of DAPT in patients undergoing PCI. DESIGN, SETTING, AND PARTICIPANTS The SMART-CHOICE trial was an open-label, noninferiority, randomized study that was conducted in 33 hospitals in Korea and included 2993 patients undergoing PCI with drug-eluting stents. Enrollment began March 18, 2014, and follow-up was completed July 19, 2018. INTERVENTIONS Patients were randomly assigned to receive aspirin plus a P2Y12 inhibitor for 3 months and thereafter P2Y12 inhibitor alone (n = 1495) or DAPT for 12 months (n = 1498). MAIN OUTCOMES AND MEASURES The primary end point was major adverse cardiac and cerebrovascular events (a composite of all-cause death, myocardial infarction, or stroke) at 12 months after the index procedure. Secondary end points included the components of the primary end point and bleeding defined as Bleeding Academic Research Consortium type 2 to 5. The noninferiority margin was 1.8%. RESULTS Among 2993 patients who were randomized (mean age, 64 years; 795 women [26.6%]), 2912 (97.3%) completed the trial. Adherence to the study protocol was 79.3% of the P2Y12 inhibitor monotherapy group and 95.2% of the DAPT group. At 12 months, major adverse cardiac and cerebrovascular events occurred in 42 patients in the P2Y12 inhibitor monotherapy group and in 36 patients in the DAPT group (2.9% vs 2.5%; difference, 0.4% [1-sided 95% CI, -infinity% to 1.3%]; P =.007 for noninferiority). There were no significant differences in all-cause death (21 [1.4%] vs 18 [1.2%]; hazard ratio [HR], 1.18; 95% CI, 0.63-2.21; P =.61), myocardial infarction (11 [0.8%] vs 17 [1.2%]; HR, 0.66; 95% CI, 0.31-1.40; P =.28), or stroke (11 [0.8%] vs 5 [0.3%]; HR, 2.23; 95% CI, 0.78-6.43; P =.14) between the 2 groups. The rate of bleeding was significantly lower in the P2Y12 inhibitor monotherapy group than in the DAPT group (2.0% vs 3.4%; HR, 0.58; 95% CI, 0.36-0.92; P =.02). CONCLUSIONS AND RELEVANCE Among patients undergoing percutaneous coronary intervention, P2Y12 inhibitor monotherapy after 3 months of DAPT compared with prolonged DAPT resulted in noninferior rates of major adverse cardiac and cerebrovascular events. Because of limitations in the study population and adherence, further research is needed in other populations. CONCLUSIONS AND RELEVANCE Among patients undergoing percutaneous coronary intervention, P2Y12 inhibitor monotherapy after 3 months of DAPT compared with prolonged DAPT resulted in noninferior rates of major adverse cardiac and cerebrovascular events. Because of limitations in the study population and adherence, further research is needed in other populations. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER MEDICAL ASSOC | - |
dc.subject | ELUTING STENT IMPLANTATION | - |
dc.subject | TREATMENT PLATELET REACTIVITY | - |
dc.subject | HIGH-RISK PATIENTS | - |
dc.subject | FOCUSED UPDATE | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | DURATION | - |
dc.subject | ASPIRIN | - |
dc.subject | CLOPIDOGREL | - |
dc.subject | METAANALYSIS | - |
dc.subject | RATIONALE | - |
dc.title | Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rha, Seung-Woon | - |
dc.identifier.doi | 10.1001/jama.2019.8146 | - |
dc.identifier.scopusid | 2-s2.0-85068040846 | - |
dc.identifier.wosid | 000473009700021 | - |
dc.identifier.bibliographicCitation | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, v.321, no.24, pp.2428 - 2437 | - |
dc.relation.isPartOf | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | - |
dc.citation.title | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 321 | - |
dc.citation.number | 24 | - |
dc.citation.startPage | 2428 | - |
dc.citation.endPage | 2437 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ELUTING STENT IMPLANTATION | - |
dc.subject.keywordPlus | TREATMENT PLATELET REACTIVITY | - |
dc.subject.keywordPlus | HIGH-RISK PATIENTS | - |
dc.subject.keywordPlus | FOCUSED UPDATE | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | DURATION | - |
dc.subject.keywordPlus | ASPIRIN | - |
dc.subject.keywordPlus | CLOPIDOGREL | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | RATIONALE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.